Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B J Monk

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Obstetrics and Gynecology|May 8, 2001
Vaginal hysterectomy as primary treatment of endometrial cancer in medically compromised womenJ K Chan, Y G Lin, B J Monk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2019
Treatment of patients with recurrent epithelial ovarian cancer for whom platinum is still an optionM Buechel, T J Herzog, S N Westin, et al.
Obstetrics and Gynecology|November 13, 2001
Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervixM T McHale, T D Le, R A Burger, et al.
Obstetrics and Gynecology|February 13, 2001
Intent-to-treat analysis of stage Ib and IIa cervical cancer in the United States: radiotherapy or surgery 1988-1995W R Brewster, B J Monk, A Ziogas, et al.
Gynecologic Oncology|January 1, 1997
Photodynamic therapy using topically applied dihematoporphyrin ether in the treatment of cervical intraepithelial neoplasiaB J Monk, C Brewer, K VanNostrand, et al.
European Journal of Gynaecological Oncology|January 31, 2014
High pathologic misdiagnosis of cervical adenocarcinoma in situS M Jordan, D M Chase, T Watanabe, et al.
Gynecologic Oncology|February 1, 1994
Open interstitial brachytherapy for the treatment of local-regional recurrences of uterine corpus and cervix cancer after primary surgeryB J Monk, J L Walker, K Tewari, et al.
American Journal of Obstetrics and Gynecology|November 1, 1994
Correlation of C-myc and HER-2/neu amplification and expression with histopathologic variables in uterine corpus cancerB J Monk, J A Chapman, G A Johnson, et al.
Journal of the American College of Surgeons|January 5, 2002
Bowel resection at the time of primary cytoreduction for epithelial ovarian cancerN Gillette-Cloven, R A Burger, B J Monk, et al.
American Journal of Obstetrics and Gynecology|July 20, 1999
Interstitial brachytherapy in the treatment of advanced and recurrent vulvar cancerK Tewari, F Cappuccini, A M Syed, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Obstetrics and Gynecology|May 8, 2001
Vaginal hysterectomy as primary treatment of endometrial cancer in medically compromised womenJ K Chan, Y G Lin, B J Monk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2019
Treatment of patients with recurrent epithelial ovarian cancer for whom platinum is still an optionM Buechel, T J Herzog, S N Westin, et al.
Obstetrics and Gynecology|November 13, 2001
Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervixM T McHale, T D Le, R A Burger, et al.
Obstetrics and Gynecology|February 13, 2001
Intent-to-treat analysis of stage Ib and IIa cervical cancer in the United States: radiotherapy or surgery 1988-1995W R Brewster, B J Monk, A Ziogas, et al.
Gynecologic Oncology|January 1, 1997
Photodynamic therapy using topically applied dihematoporphyrin ether in the treatment of cervical intraepithelial neoplasiaB J Monk, C Brewer, K VanNostrand, et al.
European Journal of Gynaecological Oncology|January 31, 2014
High pathologic misdiagnosis of cervical adenocarcinoma in situS M Jordan, D M Chase, T Watanabe, et al.
Gynecologic Oncology|February 1, 1994
Open interstitial brachytherapy for the treatment of local-regional recurrences of uterine corpus and cervix cancer after primary surgeryB J Monk, J L Walker, K Tewari, et al.
American Journal of Obstetrics and Gynecology|November 1, 1994
Correlation of C-myc and HER-2/neu amplification and expression with histopathologic variables in uterine corpus cancerB J Monk, J A Chapman, G A Johnson, et al.
Journal of the American College of Surgeons|January 5, 2002
Bowel resection at the time of primary cytoreduction for epithelial ovarian cancerN Gillette-Cloven, R A Burger, B J Monk, et al.
American Journal of Obstetrics and Gynecology|July 20, 1999
Interstitial brachytherapy in the treatment of advanced and recurrent vulvar cancerK Tewari, F Cappuccini, A M Syed, et al.
Pageof 7